Junkie News
Buprenorphine / Naloxone (Suboxone)
Citation: BML. "Junkie News: An Experience with Buprenorphine / Naloxone (Suboxone) (exp89017)". Erowid.org. May 31, 2019. erowid.org/exp/89017
DOSE: |
8 mg | sublingual | Pharms - Buprenorphine | (pill / tablet) |
2 mg | sublingual | Naloxone |
BODY WEIGHT: | 120 lb |
I did some simple research and ended up with an appointment.
Enter Suboxone prescription. That 8mg hexagonal tablet. One a day. I began taking them immediately due to the fact that in order to prove I needed them, I went to my appointment in the middle of severe withdrawals. As far as I can tell, they do the trick. The mental obsession is subdued, the aches and pains of going without my dope are gone and besides the slight drowsy euphoria, I am a new person.
Of course the first thing a user thinks when s/he gets one of these tablets is about crushing it and snorting it. Although effective, letting it dissolve under the tongue brings the effects on sooner. I have done it both ways (Including IV, which is complicated and really has no benefits).
I’d like to go in to the part about the medication that wasn’t so obvious to me when I began the treatment. The withdrawals. Much similar to withdrawals of heroin but slightly less intense. It is still enough to interfere with my everyday life. The first signs of withdrawal I notice are my mouth and throat beginning to feel dehydrated. The next thing I begin feeling is weakness throughout my entire body. I become slow and my hands may shake. That is followed by abdominal [cramps] and either diarrhea or constipation. I highly suggest weaning on or off this drug.
Exp Year: 2010 | ExpID: 89017 |
Gender: Female | |
Age at time of experience: 20 | |
Published: May 31, 2019 | Views: 1,962 |
[ View PDF (to print) ] [ View LaTeX (for geeks) ] [ Swap Dark/Light ] | |
Pharms - Buprenorphine (265) : Not Applicable (38), Medical Use (47), Addiction & Habituation (10), Retrospective / Summary (11) |
COPYRIGHTS: All reports copyright Erowid.
No AI Training use allowed without written permission.
TERMS OF USE: By accessing this page, you agree not to download, analyze, distill, reuse, digest, or feed into any AI-type system the report data without first contacting Erowid Center and receiving written permission.
Experience Reports are the writings and opinions of the authors who submit them. Some of the activities described are dangerous and/or illegal and none are recommended by Erowid Center.
No AI Training use allowed without written permission.
TERMS OF USE: By accessing this page, you agree not to download, analyze, distill, reuse, digest, or feed into any AI-type system the report data without first contacting Erowid Center and receiving written permission.
Experience Reports are the writings and opinions of the authors who submit them. Some of the activities described are dangerous and/or illegal and none are recommended by Erowid Center.
Erowid Experience Vault | © 1995-2024 Erowid |